The expression of NEDD4 is frequently upregulated in several human cancers (13–15) and positively correlated with cell proliferation and survival via ubiquitination-mediated proteosomal degradation of tumor suppressors, such as PTEN (16, 17), and LATS (18, 19). This evidence concerns the gene NEDD4 and cancer.